Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to be held on 13 March 2025. The meeting will now be held on 17 March 2025.
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13 - Jan - 2025 12:00 | 77 days ago
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13 - Jan - 2025 12:00 | 77 days ago
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to be held on 13 March 2025. The meeting will now be held on 17 March 2025.
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13 - Jan - 2025 12:00 | 77 days ago
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to be held on 13 March 2025. The meeting will now be held on 17 March 2025.
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13 - Jan - 2025 12:00 | 77 days ago
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.
Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter
13 - Jan - 2025 12:00 | 77 days ago
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023.